Computational modeling analysis revealed that the binding mechanism of compound 13 is similar to that of CA4.
The binding mechanism of compound 4i reveals that multiple hydrogen bonding interactions found between ligand and hotspot residues.
Determination of the conformations adopted in vitro and in vivo is crucial in elucidating the binding mechanism of these two compounds.
The current study was carried out to investigate the binding mechanism of a potential flavonoid compound 5-hydroxy-3′,4′,7-trimethoxyflavone 5-hydroxy-3′,4′,7-trimethoxyflavone 5-hydroxy-3′,4′,7-trimethoxyflavone 5-hydroxy-3′,4′,7-trimethoxyflavonectral measurements along witHTMFlecular docking and molecular dynamics (MD) simulation.
The study provides insight into the binding mechanism of HAPs-HBV and would be useful for the rational design and modification of new lead compounds of HAP drugs.
The focus of this study is to apply coarse-grain molecular docking procedures coupled with fine-grain all-atom force field optimization strategies to shed light on the binding mechanisms of currently available estrogen receptor-active compounds.
To further explore the binding mechanisms of these new inhibitors, we determined the X-ray structures of the complexes of FABP4-9 and FABP4-10, which revealed similar binding conformations of the two compounds.
To further define the inhibitory mechanism of compound on EV71 entry, we analyzed the binding affinity of EV71 virion to host cell with the treatment of compound.
Possible mechanisms include differential binding affinities of compounds to steroid receptor isoforms, competition between endogenous and exogenous ligands, and the formation of mixed ligand receptor complexes versus homodimers and their respective recruitment of activators or repressors of gene transcription.
